-
1
-
-
18244425608
-
Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists
-
Ambrósio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM. 1999. Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 38:1349-1359.
-
(1999)
Neuropharmacology
, vol.38
, pp. 1349-1359
-
-
Ambrósio, A.F.1
Silva, A.P.2
Malva, J.O.3
Soares-da-Silva, P.4
Carvalho, A.P.5
Carvalho, C.M.6
-
2
-
-
34047151170
-
Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions
-
Anderson WW, Collingridge GL. 2007. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods 162:346-356.
-
(2007)
J Neurosci Methods
, vol.162
, pp. 346-356
-
-
Anderson, W.W.1
Collingridge, G.L.2
-
3
-
-
0033566070
-
Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5- carboxamide derivatives
-
Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. 1999. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5- carboxamide derivatives. J Med Chem 152582-2587.
-
(1999)
J Med Chem
, pp. 152582-152587
-
-
Benes, J.1
Parada, A.2
Figueiredo, A.A.3
Alves, P.C.4
Freitas, A.P.5
Learmonth, D.A.6
Cunha, R.A.7
Garrett, J.8
Soares-da-Silva, P.9
-
4
-
-
0036202214
-
Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: A comparative review of newer versus older agents
-
Brunbech L, Sabers A. 2002. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: A comparative review of newer versus older agents. Drugs 62:593-604.
-
(2002)
Drugs
, vol.62
, pp. 593-604
-
-
Brunbech, L.1
Sabers, A.2
-
5
-
-
0026684806
-
Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture
-
Cai Z, McCaslin PP. 1992. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture. Eur J Pharmacol 219:53-57.
-
(1992)
Eur J Pharmacol
, vol.219
, pp. 53-57
-
-
Cai, Z.1
McCaslin, P.P.2
-
6
-
-
0029122730
-
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission
-
Calabresi P, De Murtas M, Stefani A, Pisani A, Sancesario G, Mercuri NB, Bernardi G. 1995. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission. Epilepsia 10:990-996.
-
(1995)
Epilepsia
, vol.10
, pp. 990-996
-
-
Calabresi, P.1
De Murtas, M.2
Stefani, A.3
Pisani, A.4
Sancesario, G.5
Mercuri, N.B.6
Bernardi, G.7
-
7
-
-
0029812585
-
A field potential analysis on the effects of lamotrigine. GP 47779, and felbamate in neocortical slices
-
Calabresi P, Siniscalchi A, Pisani A, Stefani A, Mercuri NB, Bernardi G. 1996. A field potential analysis on the effects of lamotrigine. GP 47779, and felbamate in neocortical slices. Neurology 47:557-562.
-
(1996)
Neurology
, vol.47
, pp. 557-562
-
-
Calabresi, P.1
Siniscalchi, A.2
Pisani, A.3
Stefani, A.4
Mercuri, N.B.5
Bernardi, G.6
-
8
-
-
0036251881
-
Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices
-
Cunha RA, Coelho JE, Costenla AR, Lopes LV, Parada A, de Mendonça A, Sebastião AM, Ribeiro JA. 2002. Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices. Pharmacol Toxicol 90:208-213.
-
(2002)
Pharmacol Toxicol
, vol.90
, pp. 208-213
-
-
Cunha, R.A.1
Coelho, J.E.2
Costenla, A.R.3
Lopes, L.V.4
Parada, A.5
de Mendonça, A.6
Sebastião, A.M.7
Ribeiro, J.A.8
-
9
-
-
0028350937
-
Practical aspects of oxcarbazepine treatment
-
Dam M. 1994. Practical aspects of oxcarbazepine treatment. Epilepsia 35:S23-S25.
-
(1994)
Epilepsia
, vol.35
-
-
Dam, M.1
-
10
-
-
0028350180
-
The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures
-
Dürmüller N, Craggs M, Meldrum BS. 1994. The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res 17:167-174.
-
(1994)
Epilepsy Res
, vol.17
, pp. 167-174
-
-
Dürmüller, N.1
Craggs, M.2
Meldrum, B.S.3
-
11
-
-
0036904876
-
AMPA antagonist ZK200775 in patients with acute ischemic stroke: Possible glial cell toxicity detected by monitoring of S-100B serum levels
-
Elting JW, Suiter GA, Kaste M, Lees KR, Diener HC, Hommel M, Versavel M, Teelken AW, De Keyser J. 2002. AMPA antagonist ZK200775 in patients with acute ischemic stroke: Possible glial cell toxicity detected by monitoring of S-100B serum levels. Stroke 33:2813-2818.
-
(2002)
Stroke
, vol.33
, pp. 2813-2818
-
-
Elting, J.W.1
Suiter, G.A.2
Kaste, M.3
Lees, K.R.4
Diener, H.C.5
Hommel, M.6
Versavel, M.7
Teelken, A.W.8
De Keyser, J.9
-
12
-
-
0032052684
-
Behavioral effects of NBQX, a competitive antagonist of the AMPA receptors
-
Filliat P, Pernot-Marino I, Baubichon D, Lallement G. 1998. Behavioral effects of NBQX, a competitive antagonist of the AMPA receptors. Pharmacol Biochem Behav 59:1087-1092.
-
(1998)
Pharmacol Biochem Behav
, vol.59
, pp. 1087-1092
-
-
Filliat, P.1
Pernot-Marino, I.2
Baubichon, D.3
Lallement, G.4
-
13
-
-
0027537776
-
Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment
-
Friis ML, Kristensen O, Boas J, Dalby M, Deth SH, Gram L, Mikkelsen M, Pedersen B, Sabers A, Worm-Petersen J, Andersen D, Jensen PK. 1993. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand 87:224-227.
-
(1993)
Acta Neurol Scand
, vol.87
, pp. 224-227
-
-
Friis, M.L.1
Kristensen, O.2
Boas, J.3
Dalby, M.4
Deth, S.H.5
Gram, L.6
Mikkelsen, M.7
Pedersen, B.8
Sabers, A.9
Worm-Petersen, J.10
Andersen, D.11
Jensen, P.K.12
-
14
-
-
0001219408
-
Side effect profiles and behavioral consequences of antiepileptic medications
-
Gates JR. 2000. Side effect profiles and behavioral consequences of antiepileptic medications. Epilepsy Behav 1:153-159.
-
(2000)
Epilepsy Behav
, vol.1
, pp. 153-159
-
-
Gates, J.R.1
-
15
-
-
0028365784
-
New antiepileptic drugs
-
Harden CL. 1994. New antiepileptic drugs. Neurology 44:787-795.
-
(1994)
Neurology
, vol.44
, pp. 787-795
-
-
Harden, C.L.1
-
16
-
-
2442492165
-
Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy
-
Jakus R, Graf M, Ando RD, Balogh B, Gacsalyi I, Levay G, Kantor S, Bagdy G. 2004. Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 1008:236-244.
-
(2004)
Brain Res
, vol.1008
, pp. 236-244
-
-
Jakus, R.1
Graf, M.2
Ando, R.D.3
Balogh, B.4
Gacsalyi, I.5
Levay, G.6
Kantor, S.7
Bagdy, G.8
-
17
-
-
23644441735
-
Treatment of epilepsy in adults: Expert opinion, 2005
-
Karceski S, Morrell MJ, Carpenter D. 2005. Treatment of epilepsy in adults: Expert opinion, 2005. Epilepsy Behav 7(Suppl 1):S1-S64.
-
(2005)
Epilepsy Behav
, vol.7
, Issue.SUPPL. 1
-
-
Karceski, S.1
Morrell, M.J.2
Carpenter, D.3
-
18
-
-
0036830627
-
NMDA receptor pathways as drug targets
-
Kemp JA, McKernan RM. 2002. NMDA receptor pathways as drug targets. Nat Neurosci 5(Suppl):1039-1042.
-
(2002)
Nat Neurosci
, vol.5
, Issue.SUPPL.
, pp. 1039-1042
-
-
Kemp, J.A.1
McKernan, R.M.2
-
19
-
-
0025643567
-
Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons
-
Lampe H, Bigalke H. 1990. Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport 1:26-28.
-
(1990)
Neuroreport
, vol.1
, pp. 26-28
-
-
Lampe, H.1
Bigalke, H.2
-
20
-
-
0030325604
-
Is there a mechanistic basis for rational polypharmacy?
-
Macdonald RL. 1996. Is there a mechanistic basis for rational polypharmacy? Epilepsy Res Suppl 11:79-93.
-
(1996)
Epilepsy Res
, Issue.SUPPL. 11
, pp. 79-93
-
-
Macdonald, R.L.1
-
21
-
-
0028268570
-
Mechanisms of action of currently prescribed and newly developed antiepileptic drugs
-
Macdonald RL, Kelly KM. 1994. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35:S41-S50.
-
(1994)
Epilepsia
, vol.35
-
-
Macdonald, R.L.1
Kelly, K.M.2
-
22
-
-
0042395138
-
Oxcarbazepine: Mechanism of action
-
Levy RH, Mattson RH, Meldrum BS, Perucca E, editors, 5th ed. Philadelphia: Lippincott, Williams & Wilkins. pp
-
McLean M. 2002. Oxcarbazepine: Mechanism of action. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, editors. Antiepileptic drugs, 5th ed. Philadelphia: Lippincott, Williams & Wilkins. pp 451-458.
-
(2002)
Antiepileptic drugs
, pp. 451-458
-
-
McLean, M.1
-
23
-
-
0032872770
-
Differential cognitive effects of carbamazepine and gabapentin
-
Meador KJ, Loring DW, Ray PG, Murro AM, King DW, Nichols ME, Deer EM, Goff WT. 1999. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 40:1279-1285.
-
(1999)
Epilepsia
, vol.40
, pp. 1279-1285
-
-
Meador, K.J.1
Loring, D.W.2
Ray, P.G.3
Murro, A.M.4
King, D.W.5
Nichols, M.E.6
Deer, E.M.7
Goff, W.T.8
-
24
-
-
0028535070
-
The role of glutamate in epilepsy and other CNS disorders
-
Meldrum BS. 1994. The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14-S23.
-
(1994)
Neurology
, vol.44
-
-
Meldrum, B.S.1
-
25
-
-
33846188141
-
Molecular targets for antiepileptic drug development
-
Meldrum BS, Rogawski MA. 2007. Molecular targets for antiepileptic drug development. Neurotherapeutics 4:18-61.
-
(2007)
Neurotherapeutics
, vol.4
, pp. 18-61
-
-
Meldrum, B.S.1
Rogawski, M.A.2
-
26
-
-
1542351954
-
Cognitive side effects of antiepileptic drugs
-
Ortinski P, Meador KJ. 2004. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5:S60-S65.
-
(2004)
Epilepsy Behav
, vol.5
-
-
Ortinski, P.1
Meador, K.J.2
-
27
-
-
0030682390
-
Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine
-
Phillips I, Martin KF, Thompson KS, Heal DJ. 1997. Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine. Eur J Pharmacol 337:189-195.
-
(1997)
Eur J Pharmacol
, vol.337
, pp. 189-195
-
-
Phillips, I.1
Martin, K.F.2
Thompson, K.S.3
Heal, D.J.4
-
28
-
-
0031795704
-
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: Pharmacological characterization and comparison with NBQX and L-701324 in the kindling model of epilepsy
-
Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L. 1998. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: Pharmacological characterization and comparison with NBQX and L-701324 in the kindling model of epilepsy. Br J Pharmacol 125:1258-1266.
-
(1998)
Br J Pharmacol
, vol.125
, pp. 1258-1266
-
-
Potschka, H.1
Löscher, W.2
Wlaź, P.3
Behl, B.4
Hofmann, H.P.5
Treiber, H.J.6
Szabo, L.7
-
29
-
-
0031935989
-
Complex partial and secondarily generalized seizure patients: Cognitive functioning prior to treatment with antiepileptic medication. VA Epilepsy Cooperative Study 264 Group
-
Prevey ML, Delaney RC, Cramer JA, Mattson RH. 1998. Complex partial and secondarily generalized seizure patients: Cognitive functioning prior to treatment with antiepileptic medication. VA Epilepsy Cooperative Study 264 Group. Epilepsy Res 30:1-9.
-
(1998)
Epilepsy Res
, vol.30
, pp. 1-9
-
-
Prevey, M.L.1
Delaney, R.C.2
Cramer, J.A.3
Mattson, R.H.4
-
30
-
-
0025050694
-
Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
-
Rogawski MA, Porter RJ. 1990. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223-286.
-
(1990)
Pharmacol Rev
, vol.42
, pp. 223-286
-
-
Rogawski, M.A.1
Porter, R.J.2
-
31
-
-
0036344864
-
The clinical impact of new antiepileptic drugs after a decade of use in epilepsy
-
Schmidt D. 2002. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy Res 50:21-32.
-
(2002)
Epilepsy Res
, vol.50
, pp. 21-32
-
-
Schmidt, D.1
-
32
-
-
0028559993
-
The new anticonvulsant drugs. Implications for avoidance of adverse effects
-
Schmidt D, Kramer G. 1994. The new anticonvulsant drugs. Implications for avoidance of adverse effects. Drug Saf 11:422-431.
-
(1994)
Drug Saf
, vol.11
, pp. 422-431
-
-
Schmidt, D.1
Kramer, G.2
-
33
-
-
33846487961
-
Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings
-
Sitges M, Chiu LM, Guarneros A, Nekrassov V. 2007a. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52:598-605.
-
(2007)
Neuropharmacology
, vol.52
, pp. 598-605
-
-
Sitges, M.1
Chiu, L.M.2
Guarneros, A.3
Nekrassov, V.4
-
34
-
-
35648948354
-
Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: Comparison with the Na+ channel-mediated release
-
Sitges M, Guarneros A, Nekrassov V 2007b. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: Comparison with the Na+ channel-mediated release. Neuropharmacology 53:854-862.
-
(2007)
Neuropharmacology
, vol.53
, pp. 854-862
-
-
Sitges, M.1
Guarneros, A.2
Nekrassov, V.3
-
35
-
-
0029082313
-
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents
-
Stefani A, Pisani A, De Murtas M, Mercuri NB, Marciani MG, Calabresi P. 1995. Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia 36:997-1002.
-
(1995)
Epilepsia
, vol.36
, pp. 997-1002
-
-
Stefani, A.1
Pisani, A.2
De Murtas, M.3
Mercuri, N.B.4
Marciani, M.G.5
Calabresi, P.6
-
36
-
-
13244253636
-
Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy
-
Suzuki F, Heinrich C, Boehrer A, Mitsuya K, Kurokawa K, Matsuda M, Depaulis A. 2005. Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy. Epilepsia 46:193-202.
-
(2005)
Epilepsia
, vol.46
, pp. 193-202
-
-
Suzuki, F.1
Heinrich, C.2
Boehrer, A.3
Mitsuya, K.4
Kurokawa, K.5
Matsuda, M.6
Depaulis, A.7
-
37
-
-
0028091682
-
Mechanisms of action of new antiepileptic drugs: Rational design and serendipitous findings
-
Upton N. 1994. Mechanisms of action of new antiepileptic drugs: Rational design and serendipitous findings. Trends Pharmacol Sci 15:456-463.
-
(1994)
Trends Pharmacol Sci
, vol.15
, pp. 456-463
-
-
Upton, N.1
-
38
-
-
0028866267
-
Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research
-
Vermeulen J, Aldenkamp AP. 1995. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research. Epilepsy Res 22:65-95.
-
(1995)
Epilepsy Res
, vol.22
, pp. 65-95
-
-
Vermeulen, J.1
Aldenkamp, A.P.2
-
39
-
-
0028330086
-
Developments in antiepileptic drug therapy
-
Walker MC, Sander JW. 1994. Developments in antiepileptic drug therapy. Curr Opin Neurol 7:131-139.
-
(1994)
Curr Opin Neurol
, vol.7
, pp. 131-139
-
-
Walker, M.C.1
Sander, J.W.2
-
40
-
-
0021913947
-
Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells
-
Willow M, Gonoi T, Catterall WA. 1985. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol Pharmacol 27:549-558.
-
(1985)
Mol Pharmacol
, vol.27
, pp. 549-558
-
-
Willow, M.1
Gonoi, T.2
Catterall, W.A.3
|